Least-squares means (95% confidence intervals) of daily nutrient intake of study participants in men according to frailty groups. by Subeen Kim (11714313)

Subjects:

Mean values (± standard deviation) of hormonal parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of electrolyte concentrations before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of liver profile parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of renal profile parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of lipid profile parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of CK, CK-MB and LDH before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean scores of IB-DE, IH-DE, and IB-DE items in Sample 1 and Sample 2 as well as women and men across the samples. by Aistė Ambrasė (22505574)

Subjects:

Least-squares means (95% confidence intervals) of daily nutritional intake of study participants in women according to Frailty Groups. by Subeen Kim (11714313)

Subjects:

CM-DWM-EC chart using 30% decrease in the mean for the E(KeV). by Shumaila Nisar (20114256)

“…<p>CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).</p>…”

Spearman correlation of age with proportions of cell types in men, for each brain region. by Arttu Autio-Kimura (20454681)

Characteristics of study participants in men according to frailty groups. by Subeen Kim (11714313)

Subjects:

Symbols and meanings. by Yan Wen (416285)

Men-to-women ratio across age groups. by Beat Knechtle (5504402)

“…The fastest women were in the age group 25–29 years, and the fastest men were in the age group 30–34 years. For all split disciplines and overall race time, men were always faster than women in all groups. …”

Cronbach’s alpha and means the stigma of Suicide Scale Short Form (SOSS-SF). by Orrin D. Ware (14829115)

Subjects:

DALYs for different types of cancers in Iran, 2019, a) Men; b) Women. by Mitra Darbandi (17967619)

Comparison of the albendazole and ivermectin parasitological cure rate (Intention-to-treat). by Luccheri Ndong Akomezoghe (18585684)

Subjects:

Evolution of the frequency of <i>Loa loa</i> clinical symptoms over the 30-day follow-up period. by Luccheri Ndong Akomezoghe (18585684)

Subjects:

Eosinophil rate progression by treatment. by Luccheri Ndong Akomezoghe (18585684)

Subjects:

Descriptive characteristics of the two treatment groups at the inclusion (D0). by Luccheri Ndong Akomezoghe (18585684)

Subjects: